AccessPak for HIV PEP Expanded with Kaletra and Pertuzumab Intravenous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Pertuzumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: pertuzumab
Brand name: Perjeta
Synonyms: Pertuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Pertzye
- AccessPak for HIV PEP Expanded with Kaletra-Pexeva
- AccessPak for HIV PEP Expanded with Kaletra-Pexidartinib
- AccessPak for HIV PEP Expanded with Kaletra-Pexidartinib Hydrochloride
- AccessPak for HIV PEP Expanded with Kaletra-Pfizerpen
- AccessPak for HIV PEP Expanded with Kaletra-Pharaon Tea
- Pertuzumab Intravenous-AccessPak for HIV PEP Expanded with Viracept
- Pertuzumab Intravenous-Accolate
- Pertuzumab Intravenous-Accretropin
- Pertuzumab Intravenous-Accucaine
- Pertuzumab Intravenous-AccuHist Drops
- Pertuzumab Intravenous-AccuHist PDX Drops